Advertisement

Ads Placeholder
Loading...

Syntara Limited

SNT.AX•ASX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$-0.00(-3.13%)
Australian Market opens in 61h 38m

Syntara Limited (SNT.AX) Stock Overview

Explore Syntara Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap50.7M
P/E Ratio-5.75
EPS (TTM)$-0.01
ROE-0.62%
Fundamental Analysis

AI Price Forecasts

1 Month$0.03
3 Months$0.01
1 Year Target$0.02

SNT.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Syntara Limited (SNT.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.75 and a market capitalization of 50.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.23%
5-Day Change
3.23%
1-Month Change
3.23%
3-Month Change
-5.88%
6-Month Change
14.29%
Year-to-Date (YTD) Change
-5.88%
1-Year Change
-56.16%
3-Year Change
-27.27%
5-Year Change
-61.45%
All-Time (Max) Change
-93.28%

Contact Information

https://syntaratx.com.au
61 2 9454 7200
20A Rodborough Road, Frenchs Forest, NSW, 2086

Company Facts

850 Employees
IPO DateNov 28, 2023
CountryAU
Actively Trading

Frequently Asked Questions